research Hierarchical prototype alignment and regularization for semi-supervised alopecia areata segmentation
The new method improves alopecia areata lesion detection, aiding diagnosis and treatment.
Search
forResearch
5 / 1000+ results
research AB-MTEDeep Classifier Trained with AAGAN for the Identification and Classification of Alopecia Areata
The AI model accurately classifies Alopecia Areata with 96.94% accuracy.
research PROMETHEUS: Automating Deep Causal Research Integrating Text, Data and Models
PROMETHEUS helps organize and evaluate causal claims from large language models.
research Three-dimensional reconstructions of mechanosensory end organs suggest a unifying mechanism underlying dynamic, light touch
Dynamic, light touch is sensed through a common mechanism involving Piezo2 channels in sensory axons.
research Nonsurgical Management of Facial Masculinization and Feminization
Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.
Community Join
5 / 1000+ resultscommunity Pelage Pharmaceuticals’ PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026 28th march
Pelage Pharmaceuticals' PP405 aims to treat hair loss by reactivating dormant hair follicle stem cells, showing promising results in early trials. The company plans to present their findings at the American Academy of Dermatology Annual Meeting in 2026.
community Pelage Pharmaceuticals’ PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026
PP405 shows promise in regenerating hair by activating dormant follicles. Other treatments like VDPHL01 and Breezula are also advancing, providing new hope for hair loss solutions.
community PP405 (Everychem 3HP) Anecdotes - Please assemble and share your story
PP405 (Everychem 3HP) may help with hair regrowth, with mixed user experiences. Users often combine it with minoxidil and finasteride, but there are concerns about its efficacy and side effects.
community Realistically, how much PP405 will cost?
PP405 is in phase 2 trials for hair loss, with discussions on its cost and effectiveness compared to minoxidil and finasteride. Users are skeptical about its efficacy and timeline, with hopes for market release by 2027.
community Quote from Pelage (PP-405) Spokesperson...
Pelage is developing a topical hair follicle stem cell therapy, PP405, for non-scarring alopecias like androgenetic alopecia, with Phase III trials planned and a potential market launch by 2027. The treatment may not require continuous use after initial regrowth.
Clinics
1 / 1 results
Experts
6 / 14 results- 14
Hair Transplant SurgeonDr. Tânia Data
Porto, Portugal
- 45
Hair Transplant SurgeonDr. Soumya Kanti Datta, MD, MBBS
Kolkata, West Bengal, India
- 61
Hair Loss SpecialistShainee Datta, MD, MBBS
Siliguri, West Bengal, India
- 67Hair Transplant Surgeon
Dr. Peter Dana
Calpe, Comunitat Valenciana, Spain
- 75
Hair Transplant SurgeonDr. Taariq Dada, MD, MBChB
Cape Town, South Africa
- 64
TrichologistAramide Dada
Winter Garden, FL, United States